Position in ALNY
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$305,723
-$61,705 QoQ
Shares Held
924
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HCR Wealth Advisors holds $410,873 across 2 Biotechnology names. ALNY ranks #1 (74.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
924 | $305,723 | |
| 2 | NTHI |
Neonc Technologies Holdings, Inc.
|
15,000 | $105,150 |
All Filings in ALNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $305,723 | 924 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $367,428 | 924 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $421,344 | 924 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $301,307 | 924 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $249,498 | 924 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $217,426 | 924 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $254,127 | 924 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $224,532 | 924 | Shares | Sole | 2024-08-07 | |
| 2022-12-31 | $219,588 | 924 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||